NZ526098A - Use of a plant extract containing flavonoids rich in proanthocyanidins for the prevention or treatment of migraine - Google Patents

Use of a plant extract containing flavonoids rich in proanthocyanidins for the prevention or treatment of migraine

Info

Publication number
NZ526098A
NZ526098A NZ526098A NZ52609803A NZ526098A NZ 526098 A NZ526098 A NZ 526098A NZ 526098 A NZ526098 A NZ 526098A NZ 52609803 A NZ52609803 A NZ 52609803A NZ 526098 A NZ526098 A NZ 526098A
Authority
NZ
New Zealand
Prior art keywords
migraine
plant extract
treatment
proanthocyanidins
james
Prior art date
Application number
NZ526098A
Other languages
English (en)
Inventor
Larry Ellsworth Stenswick
Sirichai Chayasirisobhon
Original Assignee
Enzo Nutraceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Enzo Nutraceuticals Ltd filed Critical Enzo Nutraceuticals Ltd
Priority to NZ526098A priority Critical patent/NZ526098A/en
Priority to MXPA05012636A priority patent/MXPA05012636A/es
Priority to AU2004241889A priority patent/AU2004241889B2/en
Priority to CN2004800205523A priority patent/CN1901928B/zh
Priority to EP04734446A priority patent/EP1631302A4/en
Priority to PCT/NZ2004/000095 priority patent/WO2004103411A1/en
Priority to CA002526631A priority patent/CA2526631A1/en
Priority to JP2006532158A priority patent/JP2007501856A/ja
Publication of NZ526098A publication Critical patent/NZ526098A/en
Priority to AU2010212521A priority patent/AU2010212521A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/13—Coniferophyta (gymnosperms)
    • A61K36/15—Pinaceae (Pine family), e.g. pine or cedar
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/82—Theaceae (Tea family), e.g. camellia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pyrane Compounds (AREA)
NZ526098A 2003-05-23 2003-05-23 Use of a plant extract containing flavonoids rich in proanthocyanidins for the prevention or treatment of migraine NZ526098A (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
NZ526098A NZ526098A (en) 2003-05-23 2003-05-23 Use of a plant extract containing flavonoids rich in proanthocyanidins for the prevention or treatment of migraine
MXPA05012636A MXPA05012636A (es) 2003-05-23 2004-05-21 Remedio para migrana.
AU2004241889A AU2004241889B2 (en) 2003-05-23 2004-05-21 Migraine remedy
CN2004800205523A CN1901928B (zh) 2003-05-23 2004-05-21 偏头痛药物
EP04734446A EP1631302A4 (en) 2003-05-23 2004-05-21 MEANS FOR THE TREATMENT OF MIGRAINE
PCT/NZ2004/000095 WO2004103411A1 (en) 2003-05-23 2004-05-21 Migraine remedy
CA002526631A CA2526631A1 (en) 2003-05-23 2004-05-21 Migraine remedy
JP2006532158A JP2007501856A (ja) 2003-05-23 2004-05-21 片頭痛治療薬
AU2010212521A AU2010212521A1 (en) 2003-05-23 2010-08-24 Migraine remedy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NZ526098A NZ526098A (en) 2003-05-23 2003-05-23 Use of a plant extract containing flavonoids rich in proanthocyanidins for the prevention or treatment of migraine

Publications (1)

Publication Number Publication Date
NZ526098A true NZ526098A (en) 2005-10-28

Family

ID=33476120

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ526098A NZ526098A (en) 2003-05-23 2003-05-23 Use of a plant extract containing flavonoids rich in proanthocyanidins for the prevention or treatment of migraine

Country Status (8)

Country Link
EP (1) EP1631302A4 (ja)
JP (1) JP2007501856A (ja)
CN (1) CN1901928B (ja)
AU (2) AU2004241889B2 (ja)
CA (1) CA2526631A1 (ja)
MX (1) MXPA05012636A (ja)
NZ (1) NZ526098A (ja)
WO (1) WO2004103411A1 (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005005275A1 (de) * 2005-02-04 2006-08-10 Peter Heger Verwendung von Hydroxystilben-haltigen Wirkstoffen zur Prävention und/oder Behandlung von Kopfschmerz und Migräne
JP2006298808A (ja) * 2005-04-19 2006-11-02 Hayashibara Biochem Lab Inc 痛覚刺激緩和剤
US20070059392A1 (en) * 2005-09-15 2007-03-15 Peter Rohdewald COX inhibitor
JP5430891B2 (ja) * 2007-10-04 2014-03-05 森永製菓株式会社 メラニン生成抑制剤
US20150237906A1 (en) * 2012-09-28 2015-08-27 Suntory Holdings Limited Monomeric proanthocyanidin-removed plant extract
CN110612103B (zh) * 2017-05-10 2023-08-22 艾克萨姆治疗公司 包含美洛昔康的药物组合物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4698360B1 (en) * 1985-04-09 1997-11-04 D Investigations Pharmacologiq Plant extract with a proanthocyanidins content as therapeutic agent having radical scavenger effect and use thereof
US6391310B1 (en) * 1996-03-13 2002-05-21 Archer Daniels Midland Company Method of preparing and using isoflavones for the treatment of neurological symptoms
US6261565B1 (en) * 1996-03-13 2001-07-17 Archer Daniels Midland Company Method of preparing and using isoflavones
AU727283B2 (en) * 1996-05-23 2000-12-07 Enzo Nutraceuticals Limited Process for extraction of proanthocyanidins from botanical material
US5939076A (en) * 1997-11-12 1999-08-17 Allocca Techical, Inc. Composition and method for treating or alleviating migraine headaches
FR2775600B1 (fr) * 1998-03-05 2000-10-06 Ravi Shrivastava Nouvelle composition pharmaceutique pour le traitement des troubles d'origine neurologique
EP1082122A4 (en) * 1998-05-27 2003-04-09 Sherwood L Gorbach ISOFLAVONOIDS USEFUL IN THE TREATMENT AND PREVENTION OF MIGRAINE HEADACHE
IT1313862B1 (it) * 1999-11-11 2002-09-24 Solvay Cassone di estremita' di un elettrodializzatore, elettrodializzatoreche comprende tale cassone di estremita' e procedimento di
AU2001288736A1 (en) * 2000-09-06 2002-03-22 A. Glenn Braswell Method and composition for enhancing vision
US20040077556A1 (en) * 2002-04-22 2004-04-22 Robert Chinery Compositions and methods for promoting weight loss, thermogenesis, appetite suppression, lean muscle mass, increasing metabolism and boosting energy levels, and use as a dietary supplement in mammals
CA2495447A1 (en) * 2002-08-06 2004-02-12 The Quigley Corporation Anti-microbial compositions and methods of using same
CA2407429C (en) * 2002-10-16 2007-02-20 Celt Corporation Composition for the regulation of the human immune system and the prevention and treatment of diseases thereof

Also Published As

Publication number Publication date
MXPA05012636A (es) 2006-05-25
CN1901928A (zh) 2007-01-24
CA2526631A1 (en) 2004-12-02
AU2004241889A1 (en) 2004-12-02
AU2010212521A1 (en) 2010-09-16
JP2007501856A (ja) 2007-02-01
WO2004103411A1 (en) 2004-12-02
EP1631302A1 (en) 2006-03-08
CN1901928B (zh) 2012-06-20
AU2004241889B2 (en) 2010-09-16
EP1631302A4 (en) 2010-07-07

Similar Documents

Publication Publication Date Title
Alok et al. Herbal antioxidant in clinical practice: A review
US11207368B2 (en) Anti-resorptive and bone building dietary supplements and methods of use
US20060188590A1 (en) Compositions for treating diabetes or obesity
US20050266018A1 (en) Nutraceutical compositions with mangosteen
DK2793905T3 (en) Composition ellagitannin-rich extracts for sexual well-being.
AU2010212521A1 (en) Migraine remedy
AU2007249801A1 (en) Food compositions and methods of treating periodontal disease
Anadón et al. Interactions between nutraceuticals/nutrients and therapeutic drugs
US20050214394A1 (en) Hippophae rhamnoides compositions for cancer therapy
Rajabalizadeh et al. Medicinal herbs in treating chemotherapy‐induced nausea and vomiting: A review
JP2006516562A (ja) 抗酸化活性を増強するための相乗的な組成物及び方法
Houston Nutrition and nutraceutical supplements for the treatment of hypertension: Part III
US20070065486A1 (en) Migraine remedy
Tejada et al. Quercetin effects on exercise induced oxidative stress and inflammation
Mitra Pharmacology and biochemistry behind the use of natural herbs to control arthritis–A review
WO2008139314A1 (en) Compositions and methods for treating joint disorders
Vanjarapu et al. A Review on Phytochemical, Biological, and Pharma-cological Effects of Psidium guajava Linn.(Guava)
WO2002067965A1 (en) Compositions based on proanthocyanadin-catechin synergies for prevention and treatment of cancer
Vasilev et al. Perioperative Herbal and Supplement Use
Duke A Philadelphia Tea Party—Rationali Tea
Mullaicharam et al. Evidence-based practice of Ginkgo biloba in brain health: A review
Detection et al. Ovarian Cancer, Chemotherapy, & Antioxidants
Detection et al. Tag: Ovarian Cancer
Braun Grape-seed Extract: Vitis Vinifera
AU2002258405A1 (en) Compositions based on proanthocyanadin-catechin synergies for prevention and treatment of cancer

Legal Events

Date Code Title Description
ASS Change of ownership

Owner name: ENZO NUTRACEUTICALS LIMITED, NZ

Free format text: OLD OWNER(S): LARRY ELLSWORTH STENSWICK; SIRICHAI CHAYASIRISOBHON

ASS Change of ownership

Owner name: MIGCO LIMITED, NZ

Free format text: OLD OWNER(S): ENZO NUTRACEUTICALS LIMITED

PSEA Patent sealed
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 21 MAY 2017 BY MATTFREVEL

Effective date: 20130518

LAPS Patent lapsed